Lifeward (LFWD) Change in Receivables (2015 - 2026)
Lifeward (LFWD) reported Change in Receivables of -$474000.0 for Q1 2026, up 43.5% on a YoY basis from -$330304.0 in Q1 2025, and down 4050.0% sequentially from $12000.0 in Q4 2025.
Lifeward (LFWD) Change in Receivables (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 12 years of Change in Receivables data on file, last reported at -$474000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 43.5% year-over-year to -$474000.0; the trailing twelve-month figure through Mar 2026 stood at $499000.0 (down 70.19% YoY), and the FY2025 full-year result was $134000.0, down 95.35% from the prior year.
- Change in Receivables eased to -$474000.0 in Q1 2026, from $12000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.8 million in Q2 2024 to a low of -$839000.0 in Q1 2025.
- A 5-year average of $191941.2 and a median of $242000.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables plunged 2300.0% in 2023 and soared 634.71% in 2024, its largest moves.
- Tracing LFWD's Change in Receivables over 5 years: stood at $546000.0 in 2022, then tumbled by 174.91% to -$409000.0 in 2023, then surged by 139.36% to $161000.0 in 2024, then tumbled by 92.55% to $12000.0 in 2025, then slumped by 4050.0% to -$474000.0 in 2026.
- Business Quant data shows LFWD's Change in Receivables at -$474000.0 in Q1 2026, $12000.0 in Q4 2025, and $262000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | -474,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -474,000.00 |
| Mar 31, 2026 | -474,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 699,000.00 |
| Mar 31, 2025 | -839,000.00 |
| Mar 31, 2025 | -839,000.00 |
| Dec 31, 2024 | 161,000.00 |
| Dec 31, 2024 | 161,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -409,000.00 |
| Dec 31, 2023 | -409,000.00 |